X

Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%

Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the previous year. The Consolidated Net Profit for the business also decreased by 8% year over year, to ₹53.6 Crore from ₹58.2 Crore. Earnings per Share is ₹6.35 for this quarter.

Related Post